Sandra Calvin
SVP, Chief Accounting Officer at Travere Therapeutics · 16 reported transactions in 1 company · latest trade Sep 15, 2026
Their trades
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days. | ||
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days. | ||
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days. | ||
Sold | Feb 3, 2026 | Feb 3, 2026 close $32.84 → Oct 29, 2026 close $50.57. S&P 500 +11.6% over the same days. | ||
Sold | Dec 24, 2025 | Dec 24, 2025 close $40.28 → Oct 29, 2026 close $50.57. S&P 500 +11.4% over the same days. | ||
Sold | Dec 15, 2025 | Dec 15, 2025 close $34.76 → Oct 29, 2026 close $50.57. S&P 500 +13.0% over the same days. |
$19.1K
Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days.
$50.3K
Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days.
$265.6K
Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days.
$139.2K
Feb 3, 2026 close $32.84 → Oct 29, 2026 close $50.57. S&P 500 +11.6% over the same days.
$296.1K
Dec 24, 2025 close $40.28 → Oct 29, 2026 close $50.57. S&P 500 +11.4% over the same days.
$104.8K
Dec 15, 2025 close $34.76 → Oct 29, 2026 close $50.57. S&P 500 +13.0% over the same days.